Wotman, M., Dagher, R., Hoff, C. O., Msherghi, A., Bonini, F., Ludmir, E. B., Wintermark, M., Ferrarotto, R. (2025). Comparing RECIST, Choi, modified Choi (mChoi) and viable tumor volume (VTV) in predicting clinical benefit of vascular endothelial growth factor receptor inhibitors (VEGFRi) in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e18145